Form 4: Cava Group Director Karen Kochevar Executes Stock Option Exercises and Sales
SEC Form 4
Director Karen Kochevar reports exercising stock options and selling shares of Cava Group, Inc. common stock on June 17, 2024.
Summary
- On June 17, 2024, Karen Kochevar, a director of Cava Group, Inc., engaged in multiple transactions involving the company's common stock.
- Kochevar exercised stock options to acquire 5,625 shares at $3.12, 3,750 shares at $6.25, and 1,875 shares at $9.58.
- Simultaneously, Kochevar sold 9,722 shares at an average price of $94.50, 5,625 shares at an average price of $92.41, 3,750 shares at an average price of $93.25, and 1,875 shares at an average price of $93.25.
- Following these transactions, Kochevar directly owns no shares of common stock but continues to hold derivative securities in the form of stock options.
Sentiment
Score: 5
Explanation: The sentiment is neutral as it simply reports transactions. It doesn't indicate positive or negative outlook for the company.
Industry Context
This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. Investors often monitor these filings for signals about management's confidence in the company's prospects.
Stakeholder Impact
- Shareholders may interpret these transactions as a signal, although it's a common practice for executives to exercise options and sell shares for personal financial management.
Key Dates
| Date | Description |
|---|---|
| 11/05/2020 | Options granted which vest in four equal annual installments commencing on August 1, 2021. |
| 08/01/2021 | First vesting date for options granted on November 5, 2020. |
| 01/25/2022 | Options granted which vest in four equal annual installments commencing on August 1, 2022. |
| 08/01/2022 | First vesting date for options granted on January 25, 2022. |
| 01/24/2023 | Options granted which vest in four equal annual installments commencing on January 24, 2024. |
| 01/24/2024 | First vesting date for options granted on January 24, 2023. |
| 06/17/2024 | Date of the reported transactions: stock option exercises and sales of common stock. |
| 08/01/2030 | Expiration date for stock options (right to buy) with an exercise price of $3.12. |
| 08/01/2031 | Expiration date for stock options (right to buy) with an exercise price of $6.25. |
| 01/24/2033 | Expiration date for stock options (right to buy) with an exercise price of $9.58. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.